Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re Google Inc. Shareholder Derivative Litigation
Case Number:
4:11-cv-04248
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
- Abraham Fruchter
- Berman Tabacco
- Chitwood Harley
- Cotchett Pitre
- Holzer & Holzer
- Johnson Fistel
- Kaplan Fox
- Pogust Goodhead
- Pomerantz LLP
- Robbins Geller
- Walker Hamilton & Kearns
- Wilson Sonsini
- Zuckerman Spaeder
Companies
Sectors & Industries:
-
August 08, 2014
Google To Spend $250M To End Investor Suit Over Pharma Ads
Google Inc. has agreed to spend a total of $250 million on product quality control to end a suit brought by shareholders after its $500 million settlement with the U.S. government for allowing Canadian pharmaceutical companies to advertise on its site, according to documents filed in California federal court Thursday.
-
July 03, 2013
Google Seeks To Ax Investor Suit Over $500M Drug Ads Deal
Google Inc. urged a California federal judge on Wednesday to toss a shareholder suit over its $500 million settlement of criminal charges for advertising Canadian prescription drugs, arguing that the plaintiffs' efforts fall short in showing Chairman Eric Schmidt knew about the activity.